Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study
Journal
European journal of preventive cardiology
Journal Volume
29
Journal Issue
2
Date Issued
2022-03-11
Author(s)
Rossi, Gian Paolo
Rossitto, Giacomo
Amar, Laurence
Azizi, Michel
Riester, Anna
Reincke, Martin
Degenhart, Christoph
Widimsky, Jiri
Naruse, Mitsuhide
Deinum, Jaap
Schultze Kool, Leo
Kocjan, Tomaz
Negro, Aurelio
Rossi, Ermanno
Kline, Gregory
Tanabe, Akiyo
Satoh, Fumitoshi
Rump, Lars Christian
Vonend, Oliver
Willenberg, Holger S
Fuller, Peter J
Yang, Jun
Chee, Nicholas Yong Nian
Margill, Steven B
Shafigullina, Zulfiya
Quinkler, Marcus
Oliveras, Anna
Kratka, Zuzana
Seccia, Teresa M
Lenzini, Livia
Abstract
We aimed at determining the rate of drug-resistant arterial hypertension in patients with an unambiguous diagnosis of primary aldosteronism (PA). Moreover, we sought for investigating the diagnostic performance of adrenal vein sampling (AVS), and the effect of adrenalectomy on blood pressure (BP) and prior treatment resistance in PA patients subtyped by AVS in major referral centres.
Subjects
Adrenal vein sampling; Aldosterone; Drug-resistant hypertension; Primary aldosteronism
Type
journal article